XyloCor Therapeutics Raises $17 Million in Series A Financing to Advance Gene Therapy Portfolio in Cardiovascular Disease

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2G43W16
via IFTTT